Based on mechanistic evidence of IgE-mediated immune surveillance, we hypothesize that AR and eczema reduce lung cancer risk via enhanced antitumor immunity, with effects modulated by allergy type, gender, and geographic context. The gene discussed is IGHE; the disease is Allergy.